Cue Biopharma Inc buy Jefferies Financial Group Inc.
Start price
13.03.24
/
50%
€1.97
Target price
13.03.25
€5.48
Performance (%)
-52.77%
End price
14.03.25
€0.93
Summary
This prediction ended on 14.03.25 with a price of €0.93. The BUY prediction by Jefferies_Financial_ for Cue Biopharma Inc performed very badly with a performance of -52.77%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cue Biopharma Inc | -8.561% | -8.561% | -61.162% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Jefferies_Financial_ for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten